Werlabs – Best Patient Platform FINALIST – 2018

Werlabs offers B2C tests across Scandinavia and the UK with revenue of over €5m and nearly 100,000 customers.

The platform works with the consumer ordering blood tests online, dropping the sample at a clinic or arranging for a pickup, getting the results back in 24 hours, the results can be viewed online in a patient journal and a doctor can add clinical context to this journal. Some 40% of its users sign up to annual subscriptions and the platform has an net promoter score of +70.

2 Countries, 200 locations, 45 staff, Revenue +5 MEUR, on way to 100,000 customers

Please list as a series of functions i.e. Make an appointment, etc.

1. Order a package of blood tests and pay for it online

2. Drop-in to a clinic linked to our service or have a phlebotomist turn up at your home and/or work

3. Get your results from an NHS or Private lab, normally within 24hrs

4. A text message is received by the general public stating that some results are available within the journal. Results are given through a secure (GDPR compliant) journal: users receive within range results without a doctor intervening.

5. A doctor checks all results, including the out of range results and gives clinical context directly into the users journal

Please list as a series of functions i.e. Make an appointment, etc.

1. Order a package of blood tests and pay for it online

2. Drop-in to a clinic linked to our service or have a phlebotomist turn up at your home and/or work

3. Get your results from an NHS or Private lab, normally within 24hrs

4. A text message is received by the general public stating that some results are available within the journal. Results are given through a secure (GDPR compliant) journal: users receive within range results without a doctor intervening.

5. A doctor checks all results, including the out of range results and gives clinical context directly into the users journal

It’s like a sneak peak into your own medical journal
Access to state laboratory testing
Assessment by experts in clinical chemistry
The convenience, speed and contextualisation of the data through product visualisation and doctor feedback.
We also directly link doctors to patients through the two-way journal
AI doctor

Month : October
Year : 2014

• How many users have signed up for the service? : nearly 100,000
• How many have subsequently become active users) (We would expect this to be a small percentage of the sign ups). Please define what exactly you mean by an active user. : 40% sign up for yearly subscription
• Have you a net promoter score for the service from active users? If so, what is it? : 70
• Has it led to any incremental increase in revenue? If so, how can you best quantify this? : NPS is hard to link to revenue